THIRD QUARTER 2019 INVESTOR PRESENTATION
October 30, 2019
Financing the Growth of Tomorrow’s Companies Today
TM
THIRD QUARTER 2019 INVESTOR PRESENTATION Financing the Growth of - - PowerPoint PPT Presentation
October 30, 2019 THIRD QUARTER 2019 INVESTOR PRESENTATION Financing the Growth of Tomorrows Companies Today TM IMPORTANT NOTICE: FORWARD LOOKING STATEMENTS This presentation may contain forward-looking statements within the meaning of
TM
This presentation may contain “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act
21E(b)(2)(B) of the Securities Exchange Act of 1934, as amended, or the Exchange Act, the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995 do not apply to forward-looking statements made in periodic reports we file under the Exchange Act. The information disclosed in this presentation is made as of the date hereof and reflects Hercules’ current assessment of its financial performance for the period reported. Actual financial results filed with the Securities and Exchange Commission in the future may differ from those contained herein in the event of additional adjustments recorded prior to the filing of its financial statements. This presentation may contain “forward-looking statements.” These forward-looking statements include comments with respect to our financial objectives, loan portfolio growth, strategies and results of our operations. However, by their nature, these forward-looking statements involve numerous assumptions, uncertainties and risks, both general and specific. The risk exists that these statements may not be fulfilled. We caution readers of this presentation not to place undue reliance on these forward-looking statements as a number of factors could cause future Company results to differ materially from these statements. Forward-looking statements may be influenced in particular by factors such as fluctuations in interest rates and stock indices, the effects of competition in the areas in which we operate, and changes in economic, political and regulatory conditions. We caution that the foregoing list is not exhaustive. When relying on forward-looking statements to make decisions, investors should carefully consider the aforementioned factors as well as other uncertainties and events. Historical results discussed in this presentation are not indicative of future results. This presentation should be read in conjunction with our recent SEC filings.
2
3
(1) Annualized based on the $0.32 distribution declared for Q3 2019 and a closing stock price of $13.37 as of September 30, 2019
Internally Managed Business Development Company (BDC)
June 9, 2005
HTGC (NYSE) – Common Stock Institutional Notes PAR $1000.00
Retail Notes (Baby Bonds) PAR $25.00
Convertible Notes
Securitization Notes
(1)
9.6% as of September 30, 2019
$0.32 per share for Q3 2019 $0.03 per share supplemental for Q3 2019
1.32x - as of October 28, 2019 ~1.3x to ~1.6x historical range
6
(1) Source: S&P CapIQ as of 9/30/19 (2) Based on NII, excludes realized and unrealized gains/losses (3) Regulatory leverage is defined as GAAP leverage excluding SBA debentures (4) As of October 28, 2019
11.1% 26.1% 35.4% 98.5% 5.2% 17.1% 19.8% 30.3% 7.1% 21.0% 32.0% 51.1% 0% 20% 40% 60% 80% 100%
1- Year 3-Year 5-Year 7-Year HTGC Peer Group Wells Fargo BDCS Index
7
(a) Peer Group: AINV, ARCC, BKCC, OCSL, FSK, GBDC, GSBD, MAIN, NMFC, OXSQ, PNNT, PSEC, SLRC, BBDC, TCPC, TCRD, TSLX (b) TSR is defined as stock appreciation plus distributed dividend distributions Source: S&P Capital IQ as of September 30, 2019
(a)
(b)
$0.33 $1.23 $2.43 $3.75 $5.01 $5.81 $6.69 $7.64 $8.75 $9.99 $11.23 $12.47 $13.71 $14.95 $16.22 $0.04 $0.02 $0.06 $0.00 $0.10 $0.20 $0.30 $0.40 $0 $2 $4 $6 $8 $10 $12 $14 $16 $18
2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 YTD Q3 2019
Cumulative Distributions Declared (per Share)
Base Distribution Supplemental Distribution
$16.30 per share or ~$920.0 million in Historical Cumulative Distributions Since June 2005 IPO 2019 YTD Distributions Paid: $1.33
10.1% 11.7% 12.6% 12.0% 13.6% 14.9% 10.8% 11.0% 9.6% 9.6% 9.7% 11.2% 0% 2% 4% 6% 8% 10% 12% 14% 16%
2014 2015 2016 2017 2018 Q3 2019
HTGC Peer Group
5.2% 6.1% 7.2% 6.3% 6.8% 7.5% 6.5% 6.0% 5.7% 5.4% 5.4% 5.7% 0% 1% 2% 3% 4% 5% 6% 7% 8%
2014 2015 2016 2017 2018 Q3 2019
HTGC Peer Group
Return on Average Assets % (ROAA)
8
Return on Average Equity % (ROAE)
(a) Peer Group: AINV, ARCC, BKCC, OCSL, FSK, GBDC, GSBD, MAIN, NMFC, OXSQ, PNNT, PSEC, SLRC, BBDC, TCPC, TCRD, TSLX (a) (a) Source: S&P Capital IQ as of 9/30/19 for HTGC and Peer Group. Return on Average Assets excluding cash. NII divided by average of beginning of period total assets excluding cash and end of period total assets excluding cash. Source: S&P Capital IQ as of 9/30/19 for HTGC and Peer Group. Return on Average Equity based on NII. NII divided by average
(1) Q1 09 distribution was paid in 10% cash and 90% stock; (2) Includes special $0.04 distribution paid in December 2009 (2) Note: The Yield Calculation may include a potential tax return of capital. Any portion of a distribution that is ultimately deemed to be a tax return of capital should not be considered. The determination of the tax attributes of the Company's distributions is made annually as of the end of the Company's fiscal year based upon its taxable income for the full year and distributions paid for the full year. Therefore, a determination made on a quarterly basis may not be representative of the actual tax attributes of its distributions for a full year. The tax attributes of its distributions for the years ended December 31, 2008 through September 30, 2019 were paid 100% from earnings and profits; however, there can be no certainty to shareholders that this determination is representative of the tax attributes of the Company’s 2019 full year distributions to stockholders.
(1, 2)
Supplemental Distributions Declared (per Share)
12.9% 10.1% 11.7% 12.6% 12.0% 13.6% 14.9%
85.8% 95.1% 83.7% 84.7% 95.5% 102.6% 111.5% 51.2% 66.2% 70.4% 84.7% 72.9% 87.0% 97.8% 44.5% 60.6% 43.9% 60.6% 62.0% 83.4%
0% 20% 40% 60% 80% 100% 120% 0% 2% 4% 6% 8% 10% 12% 14%
2013 2014 2015 2016 2017 2018 Q3 2019
ROAE GAAP Leverage Regulatory Leverage Net Regulatory Leverage
95.8%
9
(1) Source: S&P Capital IQ as of 9/30/19. Return on Average Equity based on NII. NII divided by average of beginning of period equity and end of period equity. (2) Excludes SBA (3) Excludes SBA and cash (1) (2) (3)
$9.75 $10.51 $10.18 $9.94 $9.90 $9.96 $9.90 $10.38 1.14 1.56 1.46 1.23 1.43 1.32 1.11 1.29 1.07 1.07 0.92 0.92 0.96 0.86 0.86 0.94
0.5 0.7 0.9 1.1 1.3 1.5 1.7
2012 2013 2014 2015 2016 2017 2018 Q3 2019
$8 $10 $12 $14 $16
Hercules NAV Hercules Price to NAV Peer Group Price to NAV
(a) Peer Group: AINV, ARCC, BKCC, OCSL, FSK, GBDC, GSBD, MAIN, NMFC, OXSQ, PNNT, PSEC, SLRC, BBDC, TCPC, TCRD, TSLX Source: S&P CapIQ as of 9/30/19 for HTGC and Peer Group. Stock price based on closing price on last trading day of each calendar year or relative quarter.
(a)
10
Price to NAV Multiple (x)
Net Asset Value (NAV)
$747.4 $1,123.6 $1,221.7 $1,299.2 $1,324.0 $1,464.2 $1,654.7 $1,945.2 $2,316.9
$0 $200 $400 $600 $800 $1,000 $1,200 $1,400 $1,600 $1,800 $2,000 $2,200 $2,400 2011 2012 2013 2014 2015 2016 2017 2018 YTD Q3 2019
$39.6 $48.1 $73.1 $71.8 $73.5 $100.3 $96.4 $108.7 $103.2
$0 $20 $40 $60 $80 $100 2011 2012 2013 2014 2015 2016 2017 2018 YTD Q3 2019
Net Investment Income “NII”
($ in millions)
11
$79.9 $97.5 $139.7 $143.7 $157.1 $175.1 $190.9 $207.8 $197.3
$0 $50 $100 $150 $200 2011 2012 2013 2014 2015 2016 2017 2018 YTD Q3 2019
Total Investment Income
($ in millions)
Total Assets
($ in millions)
$587.4 $914.3 $906.3 $1,035.3 $1,252.3 $1,511.5 $1,619.8 $1,980.5 $2,336.3
$0 $200 $400 $600 $800 $1,000 $1,200 $1,400 $1,600 $1,800 $2,000 $2,200 $2,400 2011 2012 2013 2014 2015 2016 2017 2018 YTD Q3 2019
Total Investments at Cost
($ in millions)
$0.5 ($1.1) $1.7 $4.3 ($26.5) ($52.9) ($50.1) ($47.0) ($32.1) ($12.0) ($6.9) ($2.3) ($29.0) ($40.1) ($26.5)
$0 $10 $20 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 YTD Q3 2019 $ in millions
$0.2 $0.5 $0.9 $1.4 $1.5 $2.1 $2.7 $3.4 $4.0 $4.9 $5.7 $6.5 $7.3 $8.5
$9.7
$0.2 $0.4 $0.7 $1.1 $1.2 $1.5 $1.9 $2.4 $2.9 $3.5 $4.2 $4.9 $5.6 $6.5
$7.3 $0.0 $1.0 $2.0 $3.0 $4.0 $5.0 $6.0 $7.0 $8.0 $9.0 $10.0 $11.0 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 YTD Q3 2019 Cumulative Commitments Cumulative Fundings $ in billions
12
HTGC IPO
Effective Annualized Loss Rate of 1.8bps or 0.018%
WARRANT HOLDINGS IN
118 companies
EQUITY HOLDINGS IN
53 companies
TOTAL WARRANT AND EQUITY GAAP COST
$235.1 million
TOTAL WARRANT AND EQUITY FAIR VALUE
$167.3 million
AVAILABLE LIQUIDITY TO INVEST(2)
$284.5 million
GAAP LEVERAGE
111.5% / 97.8% excl. SBA
INVESTMENT GRADE RATINGS
DBRS: BBB KBRA: BBB+
SECURITIZATION INVESTMENT GRADE RATINGS
KBRA: A(sf)
DEBT INVESTMENT COST BASIS
$2.10 billion
DEBT INVESTMENT FAIR VALUE
$2.08 billion
EFFECTIVE YIELD
13.4%
DEBT INVESTMENTS IN
95 companies
SHORT TERM MATURITIES
36-42 months
INVESTMENT SIZE
$5 to $200 million
FOUNDED DECEMBER 2003
IPO: June 2005 “HTGC”
ENTERPRISE VALUE
$2.59 billion(1)
MARKET CAPITALIZATION
$1.42 billion(1)
NET ASSET VALUE PER SHARE
$10.38 as of 9/30/19
HISTORICAL PRICE/NAV
~1.3x to ~1.6x range
CURRENT PRICE/NAV
1.32x(1)
WARRANT & EQUITY PORTFOLIO
COMPANIES
LIQUIDITY & BALANCE SHEET
MILLION
DEBT INVESTMENT PORTFOLIO
BILLION
14
MARKET CAPITALIZATION
BILLION
(1) As of October 28, 2019, and source for Enterprise Value and Market Capitalization is S&P Capital IQ (2) Subject to existing terms and covenants
expansion (venture growth) and established stages in a broadly diversified variety of technology, life sciences and sustainable and renewable technology industries
(1) As of September 30, 2019 15
control over leverage ratios
16
17
We Invest at the Expansion “Venture Growth” and Established Stage
$9.7 billion in total debt commitments to over 480 companies since inception Offices in key venture capital markets: CA | MA | NY | DC | IL | CT Over 1000 different VC & PE firms, financial investors Over 160 portfolio companies completed/announced an IPO or M&A event since inception
19
2019 2018 Year/Year ($ in 000's, except per share amounts) (unaudited) (unaudited) Change Interest Income $ 64,244 $ 49,092 31% Fee Income 4,994 3,510 42% Total Investment Income 69,238 52,602 32% Interest and Loan Fees 14,995 10,953 37% General and Administrative 6,368 3,721 71% Employee Compensation 9,002 8,626 4% Total Operating Expenses 30,365 23,300 30% Other Income Pre-Tax Net Investment Income-NII 38,873 29,302 33% Total Net Realized and Unrealized Gain/Loss (19,602) 6,327 Net Increase in Net Assets from Operations 19,271 35,629
NII - Net Investment Income per Share (Basic) $ 0.37 $ 0.31 19% DNOI - Distributable Net Operating Income per Share $ 0.39 $ 0.34 15% Weighted Average Shares Outstanding - Basic 104,314 95,460 9% Three Months Ended September 30,
20
Nine Months Twelve Months Ended September 30, Ended December 31, ($ in 000's, except per share amounts) 2019 2018 Interest Income $ 181,427 $ 190,636 Fee Income 15,870 17,117 Total Investment Income 197,297 207,753 Interest and Loan Fees 45,720 46,695 General and Administrative 16,316 15,488 Employee Compensation 32,088 36,841 Total Operating Expenses 94,124 99,024 Other Income
103,173 108,729 Net Realized and Unrealized Gain / (Loss) 25,814 (32,233) Net Increase in Net Assets from Operations $ 128,987 $ 76,496 NII - Net Investment Income per Share (Basic) $ 1.03 $ 1.19 DNOI - Distributable Net Operating Income per Share $ 1.13 $ 1.32 Weighted Average Shares Outstanding - Basic 99,615 90,929
21
September 30, December 31, ($ in 000's, except per share amounts) 2019 2018 ASSETS Total Investments $ 2,247,206 $ 1,880,373 Cash and cash equivalents 21,045 34,212 Restricted cash 14,886 11,645 Interest receivable 19,847 16,959 Other assets 13,945 2,002 Total Assets $ 2,316,929 $ 1,945,191 LIABILITIES Accounts Payable and Accrued Liabilites 25,451 25,961 Operating Lease Liability 11,922
11,585 52,956 2022 Convertible Notes 226,223 225,051 2027 Asset-Backed Notes 197,241 197,265 2028 Asset-Backed Notes 247,333
38,474 38,427 2024 Notes
Long-term SBA Debentures 148,038 147,655 2025 Notes 72,875 72,590 July 2024 Notes 103,723
148,383 147,990 Total Liabilites $ 1,231,248 $ 989,747 Net Assets $ 1,085,681 $ 955,444 Shares Outstanding 104,636 96,501 Net Assets per Share $ 10.38 $ 9.90
13.2% 14.4% 14.6% 14.4% 13.4% 14.9% 14.1% 14.2% 14.3% 13.5% 13.5% 13.5% 13.0% 14.3% 13.4% 12.9% 13.4% 13.2% 12.9% 12.2% 12.1% 12.6% 12.5% 11.9% 12.7% 12.7% 12.9% 12.7% 12.7% 12.4% 9.1% 9.2% 9.2% 9.2% 8.9% 9.3% 9.6% 9.8% 9.5% 10.1% 10.4% 10.4% 10.3% 10.3% 10.2% 6% 8% 10% 12% 14% 16% 18% Q1-16 Q2-16 Q3-16 Q4-16 Q1-17 Q2-17 Q3-17 Q4-17 Q1-18 Q2-18 Q3-18 Q4-18 Q1 -19 Q2-19 Q3-19
Effective Yield
GAAP Effective Yield Core Yield Loan Coupon Rate
(1) Effective Yield is inclusive of all fees, including all realized unamortized fees and all realized transaction fees including but not limited to amendment fees and prepayment fees, and is calculated based on the weighted average principal balance of loans outstanding on a daily basis (2) Core Yield excludes Early Repayments and One-Time Fees, and includes income and fees from expired commitments (2)
22
(1)
$1,205.7 $1,211.8 $1,224.1 $1,328.8 $1,311.9 $1,287.6 $1,300.1 $1,416.0 $1,336.3 $1,546.0 $1,603.3 $1,733.5 $1,897.1 $2,061.6 $2,079.9
13.2% 14.4% 14.6% 14.4% 13.4% 14.9% 14.1% 14.2% 14.3% 13.5% 13.5% 13.5% 13.0% 14.3% 13.4%
0% 2% 4% 6% 8% 10% 12% 14% 16% 18% $0 $500 $1,000 $1,500 $2,000 $2,500 Q1-16 Q2-16 Q3-16 Q4-16 Q1-17 Q2-17 Q3-17 Q4-17 Q1-18 Q2-18 Q3-18 Q4-18 Q1-19 Q2-19 Q3-19
Effective Yield (%) Total Debt Investments, at value (millions)
Total Debt Investments at Fair Value Effective Yield
(1)
23
(1) Effective Yield is inclusive of all fees, including all realized unamortized fees and all realized transaction fees including but not limited to amendment fees and prepayment fees, and is calculated based on the weighted average principal balance of loans outstanding on a daily basis
14.1%
$30,933 $34,688 $34,953 $37,418 $33,920 $37,850 $35,366 $37,159 $38,140 $36,322 $41,650 $44,946 $43,321 $54,103 $54,243
10.1% 11.0% 11.1% 11.8% 10.1% 11.1% 10.3% 10.4% 10.5% 9.5% 10.8% 11.0% 10.3% 11.8% 11.6%
0% 2% 4% 6% 8% 10% 12% 14%
$0 $10,000 $20,000 $30,000 $40,000 $50,000 $60,000
Q1-16 Q2-16 Q3-16 Q4-16 Q1-17 Q2-17 Q3-17 Q4-17 Q1-18 Q2-18 Q3-18 Q4-18 Q1-19 Q2-19 Q3-19
Net Interest Margin (%) Net Interest Margin (in thousands)
Net Interest Margin (in thousands) Net Interest Margin %(1)
24
(1) Net Interest Margin = Net Interest Income/Average Yielding Assets excluding Equity Investments
10.8%
EFFECTIVE YIELDS
UNSCHEDULED EARLY PAYOFFS ($ in millions)
1 25
13.2% 14.4% 14.6% 14.4% 13.4% 14.9% 14.1% 14.2% 14.3% 13.5% 13.5% 13.5% 13.0% 14.3% 13.4% 12.9% 13.4% 13.2% 12.9% 12.2% 12.1% 12.6% 12.5% 11.9% 12.7% 12.7% 12.9% 12.7% 12.7% 12.4% 9.1% 9.2% 9.2% 9.2% 8.9% 9.3% 9.6% 9.8% 9.5% 10.1% 10.4% 10.4% 10.3% 10.3% 10.2% 5% 10% 15% 20% Q1-16 Q2-16 Q3-16 Q4-16 Q1-17 Q2-17 Q3-17 Q4-17 Q1-18 Q2-18 Q3-18 Q4-18 Q1-19 Q2-19 Q3-19 GAAP Effective Yield Core Yield Loan Coupon Rate
$55.0 $117.6 $84.2 $67.2 $100.3 $166.4 $114.7 $124.2 $243.5 $114.3 $64.9 $63.9 $47.5 $178.3 $140.1 4.4% 9.4% 6.6% 4.9% 7.2% 12.7% 8.7% 8.7% 9.4% 7.4% 4.0% 3.6% 2.5% 8.6% 6.7%
0% 5% 10% 15% 20%
$0 $50 $100 $150 $200 $250 Q1-16 Q2-16 Q3-16 Q4-16 Q1-17 Q2-17 Q3-17 Q4-17 Q1-18 Q2-18 Q3-18 Q4-18 Q1-19 Q2-19 Q3-19 Early Payoffs Early Payoffs as % of Ending Total Debt Investment Balance at Cost
(2)
$324.0 $505.6
(1)
(1) Effective Yield is inclusive of all fees, including all realized unamortized fees and all realized transaction fees including but not limited to amendment fees and prepayment fees, and is calculated based on the weighted average principal balance of loans outstanding on a daily basis (2) Core Yield excludes Early Repayments and One-Time Fees, and includes income and fees from expired commitments
$486.6 $365.9
$64.6 $71.2 $73.9 $59.7 $75.9 $57.6 $46.3 $73.6 $51.9 $129.7 $171.9 $139.0 $154.2 $177.2 $167.5
4.8% 5.1% 5.2% 4.1% 4.8% 3.6% 2.9% 4.4% 3.2% 7.2% 9.4% 7.1% 7.2% 7.7%
7.2%
$0 $30 $60 $90 $120 $150 $180 $210 Q1-16 Q2-16 Q3-16 Q4-16 Q1-17 Q2-17 Q3-17 Q4-17 Q1-18 Q2-18 Q3-18 Q4-18 Q1-19 Q2-19 Q3-19 0% 2% 4% 6% 8% 10% 12% 14% 16%
Available Unfunded Commitments (in millions) Available Unfunded Commitments as % Total Assets
Available Unfunded Commitments (in millions) Unfunded Commitments as % of Total Assets
(1) Amount represents available unfunded commitments, including undrawn revolving facilities, which are available at the request by the portfolio company.
(1)
26
$8,265 $9,732 $9,736 $10,874 $9,410 $10,667 $9,562 $11,023 $9,769 $10,692 $10,389 $12,414 $12,025 $16,248 $12,465
2.4% 2.8% 2.8% 3.2% 2.6% 2.9% 2.5% 2.8% 2.4% 2.5% 2.4% 2.8% 2.6% 3.2% 2.4%
0% 1% 2% 3% 4%
$0 $2,000 $4,000 $6,000 $8,000 $10,000 $12,000 $14,000 $16,000 $18,000
Q1-16 Q2-16 Q3-16 Q4-16 Q1-17 Q2-17 Q3-17 Q4-17 Q1-18 Q2-18 Q3-18 Q4-18 Q1-19 Q2-19 Q3-19
OPEX as a % of Total Assets (%) OPEX (in thousands)
OPEX (exc. Interest, fees, RSU, PSU and option expense) OPEX as a % of Average Total Assets
27
2.6%
Credit Grading at Fair Value, Q3 2019 - Q3 2018 ($ in millions) Q3 2019 Q2 2019 Q1 2019 Q4 2018 Q3 2018 Grade 1 - High 237.9 $ 11.4% 256.2 $ 12.4% 299.2 $ 15.8% 311.6 $ 18.0% 150.2 $ 9.4% Grade 2 1,331.2 $ 64.0% 1,317.7 $ 63.9% 1,056.4 $ 55.7% 885.1 $ 51.1% 987.5 $ 61.6% Grade 3 479.0 $ 23.1% 413.0 $ 20.1% 469.7 $ 24.7% 474.9 $ 27.3% 420.2 $ 26.2% Grade 4 29.7 $ 1.4% 67.8 $ 3.3% 66.5 $ 3.5% 60.3 $ 3.5% 44.5 $ 2.7% Grade 5 - Low 2.1 $ 0.1% 6.9 $ 0.3% 5.3 $ 0.3% 1.6 $ 0.1% 0.9 $ 0.1% Weighted Avg. 2.17 2.18 2.19 2.18 2.23
(1) Debt only; based on fair value
$1,205.7 $1,211.8 $1,224.1 $1,328.8 $1,311.9 $1,287.6 $1,300.1 $1,416.0 $1,336.3 $1,224.1 $1,603.3 $1,733.5 $1,897.1 $2,061.6 $2,079.9 2.17 2.11 2.32 2.41 2.43 2.27 2.24 2.17 2.43 2.21 2.23 2.18 2.19 2.18 2.17 1.0 2.0 3.0 4.0 5.0
$0 $500 $1,000 $1,500 $2,000 $2,500
Q1-16 Q2-16 Q3-16 Q4-16 Q1-17 Q2-17 Q3-17 Q4-17 Q1-18 Q2-18 Q3-18 Q4-18 Q1-19 Q2-19 Q3-19
Credit Rating Debt Portfolio Value
($ in millions) Debt Portfolio Value Weighted Investment Credit Rating
(1)
High Quality Low Quality
28
29
Capital Sources as of 9/30/19 $ in Millions % of Total Equity $1,085.7 47.3% SBA Debentures $149.0 6.5% 2027 Asset-Backed Notes $200.0 8.7% 2028 Asset-Backed Notes $250.0 10.9% 2022 Convertible Notes $230.0 10.0% 2022 Notes (Institutional) $150.0 6.5% 2024 Notes (Institutional) $105.0 4.6% 2025 Notes (Baby Bonds) $75.0 3.3% 2033 Notes (Baby Bonds) $40.0 1.7% Credit Facilities $11.6 0.5% Total Capital $2,296.3 100.0%
SBA Debentures 6.5% Equity 47.3% 2027 Asset-Backed Notes 8.7% Credit Facilities 0.5% 2022 Convertible Notes 10.0% 2028 Asset-Backed Notes 10.9% 2025 Notes (Baby Bonds) 3.3% 2033 Notes (Baby Bonds) 1.7% 2024 Notes 4.6% 2022 Notes (Institutional) 6.5%
$75.0
2024 Notes 7.1% Wells Fargo 5.1% Union Bank 13.6% 2022 Convertible Notes 15.6% 2027 Asset Backed Notes 13.6% 2028 Asset Backed Notes 17.0% 2033 Notes 2.7% SBA License 2 - HTII… 2025 Notes 5.1% 2022 Notes 10.2%
$75.0 $200.0 $230.0 $149.0 $200.0 ($ in millions) $150.0 $40.0 $250.0 $105.0 $75.0
(1) Interest rate range for the SBA debentures does not include annual fees
30 ($ in millions)
(2)
Wells Fargo Credit Facility Union Bank Credit Facility Notes SBA Debentures Securitizations January 2022
October 2022
April 2025 Notes October 2033 Notes July 2024 Notes License 2 HTIII DATE ENTERED
April 2018 October 2018 July 2019 May 2010
January 2019 FACILITY SIZE
($ in millions)
$75.0 $200.0 $230.0 $150.0 $75.0 $40.0 $105.0 $149.0 $200.0 $250.0
INTEREST RATE LIBOR + 300bps LIBOR + 270bps 4.375% unsecured 4.625% unsecured 5.25% unsecured 6.25% unsecured 4.77% unsecured Range(1) from 2.2% to 5.5% 4.605% 4.703% MATURITY January 2022 February 2022 February 2022 October 2022 April 2025 October 2033 July 2024 Mature 10 years after borrowing November 2027 February 2028 ADDITIONAL INFO (Expandable up to $125.0) (Expandable up to $300.0) DBRS: BBB KBRA: BBB+ DBRS: BBB KBRA: BBB+ NYSE: HCXZ DBRS: BBB KBRA: BBB+ NYSE: HCXY DBRS: BBB KBRA: BBB+ KBRA: BBB+
Set in March & Sept. (range: 2.2% to 5.5%)
Rated A(sf) by KBRA Rated A(sf) by KBRA OUTSTANDING
($ in millions)
$0.0 $11.6 $230.0 $150.0 $75.0 $40.0 $105.0 $149.0 $200.0 $250.0
$200.0 $250.0 $230.0 $10.0 $53.8 $60.5 $24.8 $40.0 $150.0 $105.0 $75.0 $0 $100 $200 $300 $400 2020 2021 2022 2023 2024 2025 2027 2028 2033
Securitization Convertible Notes SBA Bonds October 2033 Notes October 2022 Notes July 2024 Notes April 2025 Notes
32
0.2% 0.3% 2.0% 31.7% 3.4% 4.7% 2.6% 18.8% 1.0% 4.5% 0.5% 26.1% 0.0% 0.2% 0.3% 0.2% 3.5% Communications & Networking Consumer & Business Products Drug Delivery Drug Discovery & Development Sustainable & Renewable Technologies Healthcare Services, Other Information Services Internet Consumer & Business Services Media/Content/Info Medical Devices & Equipment Semiconductors Software Specialty Pharmaceuticals Diagnostic & Surgical Devices Electronics & Computer Hardware Biotechnology Tools Diversified Financial Services
97.6% 2.4% Floating Fixed 78.5% 14.1% 6.6% 0.8%
Equity Investments Warrant Positions
Floating vs. Fixed Rate Investment Type Breakout Industry Breakout Hercules Investments by Geography 42% 6% 4% 37% 5% International: 6%
(As of December 31, 2018)
Fastly, BridgeBio, Brickell Biotech and Oportun Financial completed IPOs
Group, and Brickell Biotech
33
$37.4M x 2X multiple: $74.1M - $17.0M cost = $57.1M unrealized gain = $0.55/share $37.4M x 3X multiple: $112.2M - $17.0M cost = $95.2M unrealized gain = $0.91/share $37.4M x 4X multiple: $149.6M - $17.0M cost = $132.6 unrealized gain = $1.27/share
34
34
24.1% 26.2% 23.7% 29.7% 23.9% 28.7% 31.7% 2.2% 5.1% 4.3% 2.7% 2.4% 11.4% 13.5% 7.5% 7.6% 6.1% 6.5% 4.5% 5.2% 2.6% 1.6% 2.6% 6.8% 8.7% 13.7% 7.7% 5.9% 2.2% 2.0% 13.4% 6.8% 7.4% 6.8% 10.0% 17.5% 18.8% 2.9% 9.7% 9.9% 1.2% 1.0% 7.2% 12.3% 12.3% 15.4% 23.4% 29.2% 26.1% 18.1% 6.7% 13.3% 10.9% 7.7% 5.9% 3.4% 1.5% 2.0%
6.2%
3.0% 1.3%
0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100% 2013 2014 2015 2016 2017 2018 Q3 2019 % Total Investment Portfolio at Fair Value
Diversified Financial Services Electronics & Computer Hardware Consumer & Business Products Diagnostic & Surgical Device Healthcare Services, Other Sustainable & Renewable Software Semiconductors Media/Content/Info Internet Consumer & Business Services Drug Delivery Information Services Communications & Networking Medical Devices & Equipment Specialty Pharmaceuticals Drug Discovery & Development Biotechnology Tools
$910.3 $1,020.7 $1,200.6
($M)
$1,423.9
35
8.0% 4.0%
$1,542.2
4.7%
$1,880.4
3.2%
2.1%
$2,247.2
3.5%
4.7% 4.0% 6.0% 2.8%
36
36
Equity-only Investments
Palo Alto Boston New York Washington DC Chicago Hartford
37
Source: Dow Jones VentureSource Q3 2019 39
$26.9 $54.6 $85.5 $42.5 $12.5 $10.4 $18.9 $29.0 $31.9 $39.3 $29.8 $14.9 $17.9 $21.0 $23.4 $21.8 $37.1 $39.0 $44.9 $39.0 $56.2 $40.6 $0 $10 $20 $30 $40 $50 $60 $70 $80 $90
1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2016 2014 2015 2016 2017 2018 YTD Q3 2019
Funds Raised (billions)
$13.1 $17.9
$49.5 $94.1 $36.8 $22.6 $20.3 $23.6 $25.1 $31.2 $34.5 $33.3 $25.2 $28.9 $36.7 $34.8 $36.4 $58.5 $84.7 $60.2 $79.6 $107.6 $78.8
2,211 2,547 4,590 6,350 3,341 2,484 2,294 2,462 2,633 2,892 3,155 3,123 2,799 3,204 3,729 3,906 4,048 4,278 4,379 4,295 4,625 4,941 3,323
500 1,500 2,500 3,500 4,500 5,500 6,500 $0 $20 $40 $60 $80 $100 $120
1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 YTD Q3 2019
# of Deals Dollars Invested (billions) $ in billions # of deals
Note: Represents VC investments only Source: Dow Jones VentureSource Q3 2019
0% 20% 40% 60% 80% 100%
2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019
IPOs M&A
5.4 6.0 6.5 5.8 5.5 5.2 5.2 5.2 5.0 5.2 4.9 5.2 5.0 5.3 5.5 5.6 6.2 6.8 8.7 7.9 7.4 6.2 7.1 6.6 6.8 6.1 6.6 7.5 5.4 6.4
2 4 6 8 10
2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019
IPOs M&A
40
Less dilutive than new VC round
Lengthens time before next equity round
Provides negotiating leverage for higher valuations
Leverages returns
Source: Dow Jones VentureSource Q3 2019
Median Time from Initial Equity Funding Breakdown of Venture Backed Liquidity Events
Source: Dow Jones VentureSource Q3 2019 YTD YTD
Source: Dow Jones VentureSource Q3 2019 41
$26.5 $22.8 $55.6 $58.2 $76.3 $65.5 $132.0 $93.9 $121.7 $89.8 $133.1 $90.2
456 440 667 652 608 604 687 633 655 683 726 538
100 200 300 400 500 600 700 800 900 $0 $20 $40 $60 $80 $100 $120 $140 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 YTD Q3 2019
# of Deals Amount Paid (billions)
$ in billions # M&A Deals
$0.6 $0.9 $3.9 $7.1 $12.1 $9.6 $12.0 $8.0 $2.8 $9.9 $11.2 $23.3
9 8 53 52 58 87 126 79 41 60 82 61
20 40 60 80 100 120 140 $0 $5 $10 $15 $20 $25 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 YTD Q3 2019
# of IPOs Amount Raised (billions)
$ in billions # of IPOs
Source: Dow Jones VentureSource Q3 2019
Commitments as % of VC Dollars Invested
0.9% 0.8% 1.4% 1.2% 0.8% 1.8% 1.7% 1.8% 1.9% 1.6% 1.0% 1.6% 1.1% 1.1% 1.5%
Source: Dow Jones VentureSource Q3 2019
42 Note: Represents VC investments only
$25.1 $31.2 $34.5 $33.3 $25.2 $28.9 $36.7 $34.8 $36.4 $58.5 $84.7 $60.2 $79.6 $107.6 $78.8
$215 $243 $494 $413 $186 $523 $630 $637 $705 $905 $745 $807 $882 $1,213 $1,191 $0 $20 $40 $60 $80 $100 $120 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 YTD Q3 2019 $0 $200 $400 $600 $800 $1,000 $1,200 $1,400
VC Dollars Invested (billions) Hercules Debt and Equity Commitments (millions)
VC Dollars Invested Hercules Debt & Equity Commitments
Source: Dow Jones VentureSource Q3 2019 43
53 52 57 87 126 78 41 60 2 2 7 5 8 7 1 3 3 11 2 4 6 8 10 12 20 40 60 80 100 120 140
2010 2011 2012 2013 2014 2015 2016 2017 2018 YTD Q3 2019
Hercules’ Portfolio Company IPOs Venture Backed IPOs
VC-backed IPOs Hercules' PoCo IPOs
Participation as % of Total VC-Backed IPOs
61 82
44
46
Finian O’Shea (Transferred Coverage 7/13/2018) Ryan Lynch (Re-initiated Coverage 2/19/2013) Aaron James Deer (Initiated Coverage 9/29/2011) John Hecht (Initiated Coverage 6/30/2015) Casey Alexander (Initiated Coverage 6/23/15) Mitchel Penn (Initiated Coverage 1/14/2015) Chris York (Initiated Coverage 10/24/2012) Tim Hayes (Re-initiated Coverage 10/2/2017) Henry Coffey (Initiated Coverage 10/24/17) Christopher Nolan (Initiated Coverage 11/20/2017)
Hercules Capital is followed by the analysts listed above. Please note that any opinions, estimates or forecasts regarding Hercules Capital’s performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of Hercules Capital or its management. Hercules Capital does not by its reference above or distribution imply its endorsement of
debt
Administration (“SBA”)
BDC 2:1 leverage test
48
49
Follow-on Rounds
(Series B-Liquidity Event) Private Late Stage/ Select Public Companies
Venture Capital/ Private Equity Public Markets/ Private Equity
1–3 Additional Rounds 0–2 Additional Rounds
3–7 x 2–4 x
4–6 years 2–4 years
$0.03 $0.06 $0.10 $0.15 $0.34
$0.00 $0.10 $0.20 $0.30 $0.40 $0.50
$0 $10,000 $20,000 $30,000 $40,000 $50,000
Earning per Share(1) Net Income ($ in thousands) Basis Point Movement in Prime Rate
Net Income EPS
(1) EPS calculated on basic weighted shares outstanding of 104.3 million and a static debt investment portfolio as of September 30, 2019. Estimates are also subject to change due to impact from potential participation in the Company’s equity ATM program and future equity offerings. 50